Family Medicine · Dothan, AL
NPI
1417971037
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
4300 W Main St, Suite 16
Dothan, AL, 36305
Phone (334) 793-4120
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
6,779 services
Medicare patients, 2024
284
Average age 74
Drug cost, 2024
$1.1M
14,429 prescriptions
Company payments, 2025
$223
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana M Mancuso was code J1010 (injection, methylprednisolone acetate, 1 mg), 4,560 times for 38 patients. In total Diana M Mancuso billed 6,779 services in 42 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,560 | 38 | $0.10 | $439 |
| 99214 Office E&M - Established | Office | 405 | 196 | $66.79 | $27K |
| 82947 Clinical Chemistry | Office | 347 | 102 | $3.80 | $1,318 |
| 99213 Office E&M - Established | Office | 345 | 152 | $49.79 | $17K |
| 81000 Clinical Chemistry | Office | 270 | 176 | $3.91 | $1,056 |
| 99211 Office E&M - Established | Office | 134 | 65 | $11.50 | $1,541 |
| G0008 Administration of influenza virus vaccine | Office | 95 | 91 | $29.15 | $2,769 |
| 99232 Hospital E&M - Subsequent | Facility | 88 | 48 | $55.68 | $4,900 |
| 90653 Vaccine Product | Office | 79 | 79 | $80.78 | $6,382 |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 46 | $83.35 | $6,168 |
| 87811 Immunoassay | Office | 41 | 36 | $40.55 | $1,663 |
| G0009 Administration of pneumococcal vaccine | Office | 39 | 39 | $29.46 | $1,149 |
| 90677 Vaccine Product | Office | 33 | 33 | $291.24 | $9,611 |
| 99215 Office E&M - Established | Office | 32 | 26 | $106.34 | $3,403 |
| 36415 Venipuncture Blood Collection | Office | 30 | 28 | $8.65 | $260 |
By year: 2022 $88K for 2,486 services; 2023 $84K for 2,080 services; 2024 $96K for 6,779 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 347 | 102 | $3.80 | $1,318 |
| 81000 Clinical Chemistry | 270 | 176 | $3.91 | $1,056 |
| 87811 Immunoassay | 41 | 36 | $40.55 | $1,663 |
| 36415 Venipuncture Blood Collection | 30 | 28 | $8.65 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Diana M Mancuso prescribed most often to Medicare patients was Losartan Potassium, with 841 prescriptions and refills. In total Diana M Mancuso wrote 14,429 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 841 | 2,218 | 219 | $8,034 |
| Levothyroxine Sodium Generic | 819 | 1,961 | 181 | $7,940 |
| Atorvastatin Calcium Generic | 661 | 1,728 | 186 | $6,152 |
| Alprazolam Generic | 485 | 487 | 62 | $1,296 |
| Rosuvastatin Calcium Generic | 431 | 1,056 | 122 | $5,341 |
| Omeprazole Generic | 385 | 1,031 | 111 | $5,465 |
| Pravastatin Sodium Generic | 351 | 976 | 88 | $5,274 |
| Amlodipine Besylate Generic | 334 | 740 | 85 | $1,884 |
| Potassium Chloride Generic | 265 | 586 | 69 | $4,799 |
| Pantoprazole Sodium Generic | 257 | 595 | 67 | $3,027 |
| Gabapentin Generic | 241 | 538 | 72 | $4,133 |
| Tramadol Hcl Generic | 235 | 235 | 45 | $1,217 |
| Atenolol Generic | 233 | 651 | 62 | $1,531 |
| Clonidine Hcl Generic | 219 | 579 | 59 | $1,278 |
| Furosemide Generic | 211 | 545 | 62 | $1,004 |
Brand drugs: 1,784 claims; generic drugs: 12,533 claims; opioid claims: 496.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana M Mancuso $223 ($223 in general payments such as food, travel and fees) from 4 companies. The largest payer was Lilly USA, LLC with $59.17.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.